Understanding Drug Action and Resistance to Improve Patient Stratification

29 Jan 2026
Precision Medicine & Patient Stratification Stage
  • Explore how integrating molecular profiling with functional drug-response data reveals the mechanisms driving both therapeutic efficacy and resistance in cancer. 

  • Demonstrate how identifying resistance pathways and predictive biomarkers enables more precise patient stratification and supports the design of individualized treatment strategies. 

  • Highlight emerging approaches to map drug mechanisms of action and guide the development of more effective, targeted therapies. 

Speakers
Silvia-Elena Glont
Silvia-Elena Glont, Senior Scientist, Translational Genomics - AstraZeneca